Analyst Ratings For CVS Health
Within the last quarter, CVS Health (NYSE:CVS) has observed the following analyst ratings:
Is Now The Time To Buy Stock In DiDi Global, Affirm, Zoom Or CVS Health?
One of the most common questions traders have about stocks is “Why Is It Moving?”
Raymond James Downgrades CVS Health to Outperform, Raises Price Target to $120
Raymond James analyst John Ransom downgrades CVS Health (NYSE:CVS) from Strong Buy to Outperform and raises the price target from $115 to $120.
BZ Chart Of The Day: CVS Slams Into Wall of Sellers
There’s an old belief on Wall Street that markets have memories. Shares of CVS Health Corporation (NYSE: CVS) show that it’s true.
Benzinga’s Daily Brief On Trending Tickers For Feb. 9, 2022: Peloton, GameStop And More
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.
Mid-Morning Market Update: Markets Open Higher; Nasdaq Gains Over 1%
US stocks opened on strong note on Wednesday, while the Nasdaq Composite surging more than 1% this morning.
CVS Health: Q4 Earnings Insights
CVS Health (NYSE:CVS) reported its Q4 earnings results on Wednesday, February 9, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
CVS Health Fourth Quarter Performance Gets A Boost From COVID-19 Vaccinations, Reaffirms FY22 Outlook
CVS Health Corporation's (NYSE: CVS)
5 Stocks To Watch For February 9, 2022
Some of the stocks that may grab investor focus today are:
Wall Street expects CVS Health Corporation (NYSE: CVS) to report quarterly earnings at $1.83 per share on revenue of $75.55 billion before the opening bell. CVS shares rose 1.1% to $112.00 in after-hours trading.